Lincoln, RI, United States of America

Andrew Mallon

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew Mallon: Innovator in Long-Term Potentiation Research

Introduction

Andrew Mallon is a notable inventor based in Lincoln, Rhode Island. He has made significant contributions to the field of neuroscience, particularly in the area of long-term potentiation (LTP). His work focuses on the mechanisms that facilitate learning and memory, which are crucial for understanding various neurological conditions.

Latest Patents

Mallon holds a patent for his invention titled "Long term potentiation with cyclic-GluR6 analogs." This patent discloses CN2097-like compositions that facilitate the induction of long-term potentiation. In one embodiment, the method comprises inducing long-term potentiation in a subject by administering a therapeutically effective dose of a CN2097-like compound. This innovative approach has the potential to advance therapeutic strategies for cognitive enhancement and memory-related disorders.

Career Highlights

Andrew Mallon is affiliated with Brown University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its implications in both basic and applied neuroscience. With a focus on the molecular underpinnings of synaptic plasticity, Mallon continues to explore new avenues for enhancing cognitive function.

Collaborations

Mallon has worked alongside John Marshall, contributing to a collaborative environment that fosters innovation and discovery. Their joint efforts aim to deepen the understanding of LTP and its applications in therapeutic contexts.

Conclusion

Andrew Mallon's contributions to the field of neuroscience through his patent and research at Brown University highlight his role as an innovator in long-term potentiation. His work not only advances scientific knowledge but also holds promise for future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…